Moderator: Steering Committee
Imatinib mesilate is authorised in the European Union for treatment of adult persons with myelodysplastic diseases according to European Medicines Agency
Imatinib has been in the news lately as cheaper generic versions are now allowed to be produced in certain counties. (India)
Has anyone ever been treated for MDS as by way of a trial or otherwise with Imatinib and if so what were the results.
Good results have been achieved and reported for sufferers of leukemia in extending life expectancy , could the same results be achieved for MDS.
I would be interested in any comments.
- Posts: 601
- Joined: 01 Dec 2009 21:52
- Location: Essex
Yes, I heard that on the news too and my ears pricked up!! As I understand it, there are only a small number of leukaemia and MDS patients (CMML mainly I believe) with a certain specific type of chromsomal abnormality that respond very well to this drug - also called Gleevec. Here's a link. But personally, no experience and I have not heard of trials of this drug for MDS generally
http://www.lls.org/content/nationalcont ... mljmml.pdf
Have a peruse.
Users browsing this forum: No registered users and 2 guests